.Pharmacolibrary.Drugs.R_RespiratorySystem.R01A_DecongestantsAndOtherNasalPreparationsForTopical.R01AX02_Retinol.Retinol .Pharmacolibrary.Drugs.R_RespiratorySystem.R01A_DecongestantsAndOtherNasalPreparationsForTopical.R01AX02_Retinol.Retinol| name: | Retinol | |
| ATC code: | R01AX02 | route: | oral |
| compartments: | 1 | |
| dosage: | 5000 | mg |
| volume of distribution: | 1.0 | L |
| clearance: | 0.8 | L/h |
| other parameters in model implementation | ||
Retinol, also known as vitamin A1, is an essential fat-soluble vitamin important for vision, immune system function, and cellular growth and differentiation. It is not typically used as a drug for direct treatment but is provided as a nutritional supplement to prevent or treat vitamin A deficiency. It is not classified as an approved prescription medicine for specific diseases in most regulatory systems.
No published studies reporting specific pharmacokinetic parameters for retinol administered as a drug with ATC code R01AX02 (nasal use). Estimates are based on general oral or parenteral supplementation data for retinol in healthy adults.
Haskell, MJ, et al., & Brown, KH (2003). Population-based plasma kinetics of an oral dose of [2H4]retinyl acetate among preschool-aged, Peruvian children. The American journal of clinical nutrition 77(3) 681–686. DOI:10.1093/ajcn/77.3.681 PUBMED:https://pubmed.ncbi.nlm.nih.gov/12600861
Lopez-Teros, V, et al., & Astiazaran-Garcia, H (2020). The "Super-Child" Approach Is Applied To Estimate Retinol Kinetics and Vitamin A Total Body Stores in Mexican Preschoolers. The Journal of nutrition 150(6) 1644–1651. DOI:10.1093/jn/nxaa048 PUBMED:https://pubmed.ncbi.nlm.nih.gov/32135013
Kelly, P, et al., & Farthing, MJ (2001). Impaired bioavailability of vitamin A in adults and children with persistent diarrhoea in Zambia. Alimentary pharmacology & therapeutics 15(7) 973–979. DOI:10.1046/j.1365-2036.2001.01021.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/11421872